Aerocrine Launches a New Fully Portable Hand-Held Device to Measure Airway Inflammation in Asthma

Published: Sep 11, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SOLNA, Sweden – 11 September, 2013 - Aerocrine AB (OMX Nordic Exchange: AERO) is pleased to announce the launch of NIOX VERO®, a new, fully portable hand-held point-of-care device for the measurement of airway inflammation, such as asthma. Aerocrine introduces the new device in conjunction with the European Respiratory Society (ERS) annual meeting in Barcelona, September 7-11, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news